Search Results - "Obando, Camilo"

Real‐world evidence on adherence, persistence, switching and dose escalation with biologics in adult inflammatory bowel disease in the United States: A systematic review by Khan, Shahnaz, Rupniewska, Ewa, Neighbors, Mackenzie, Singer, David, Chiarappa, Joseph, Obando, Camilo

“…Summary What is known and objective The application of biologics to treat inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis,…”
Get full text

Sa1737 - Cost Per Responder and Cost Per Remitter Analysis of Ustekinumab Compared to Adalimumab Among Patients with Moderate-to-Severe Crohn's Disease in the United States: An Analysis of the Failure to Conventional Therapy Subgroup by Obando, Camilo, Gasink, Christopher, Naessens, Dominik

Get full text

S0762 Nonbiologic Drug Use One Year Before and Two Years After Initiation of Ustekinumab or Adalimumab for Crohn's Disease Patients by Muser, Erik, Obando, Camilo, Ding, Zhijie, Slaton, Terra, Kozma, Chris

Get full text

Mo1876 TREATMENT PERSISTENCE AND MAINTENANCE DOSING FOR USTEKINUMAB AND ADALIMUMAB AMONG PATIENTS WITH CROHN'S DISEASE WITH TWO-YEARS FOLLOW-UP IN THE SYMPHONY HEALTH DATABASE by Muser, Erik, Obando, Camilo, Ding, Zhijie, Slaton, Terra, Kozma, Chris

Get full text

Effect of Ponesimod Compared With Teriflunomide on Treatment With Concomitant Corticosteroids for Relapse in Patients with Relapsing Forms of Multiple Sclerosis (P5-4.008) by Obando, Camilo, Turkoz, Ibrahim, Simples, James, Doring, Monica, Ait-Tihyaty, Maria

“…Abstract only…”
Get full text

Mo1908 – Nonbiologic Drug Use Before and After Initiation of Ustekinumab Or Adalimumab for Crohn’s Disease Patients by Obando, Camilo, Ding, Zhijie, Muser, Erik, Slaton, Terra, Kozma, Chris

Get full text

Su1872 – Evaluation of Real-World Maintenance Dosing for Ustekinumab and Adalimumab Among Patients with Crohn’s Disease with At Least One-Year Follow-Up in the Symphony Health Database by Obando, Camilo, Ding, Zhijie, Muser, Erik, Slaton, Terra, Kozma, Chris

Get full text

Early Assessment of Ustekinumab for Crohnʼs Disease: A Chart Review: 2821 by Ruetsch, Charles, Davis, Tigwa, Clerie, Jennifer, Muser, Erik, Obando, Camilo

Get full text

Mo1779 - Evaluate the Treatment Patterns and Healthcare Utilizations for Biologic Therapies for Crohn's Disease by Obando, Camilo, Xie, Lin, Vaidya, Neel, Sah, Janvi

Get full text

Sa1778 - Number Needed to Treat to Achieve Clinical Response at Week 8 Along with Response or Remission at Week 52 with Ustekinumab Treatment vs Placebo from the Phase 3 Uniti Crohn's Disease Studies, by Population by Ghosh, Subrata, Gasink, Christopher, Gao, Long-Long, Obando, Camilo

Get full text

Su1827 ALIGNMENT OF IBD SYMPTOMS REPORTED BY PATIENTS AND THEIR TREATING PHYSICIANS IN THE US by Ding, Zhijie, Muser, Erik, Obando, Camilo, Izanec, James L., Sikirica, Mirko, Lukanova, Rina, Meakin, Sophie

Get full text

Real-World Persistence, Maintenance Dosing, and Pre-Post Corticosteroid and Opioid Use Among Crohn’s Disease Patients with Prescription Claims for Ustekinumab in the USA by Ding, Zhijie, Obando, Camilo, Muser, Erik, Kozma, Chris, Slaton, Terra

“…Background Real-world evidence for how US Crohn’s disease (CD) patients use ustekinumab is limited. Objectives The aim of this study was to describe the…”
Get full text

P037 Patterns of Care Among Patients Treated With Ustekinumab for Crohn’s Disease: Results From a Chart Review by Ruetsch, Charles, Davis, Tigwa, Clerie, Jennifer, Obando, Camilo, Izanec, James, Muser, Erik

“…BACKGROUND: Crohn’s Disease (CD) is a chronic, progressive disease that causes severe and debilitating symptoms often leading to hospitalizations and…”
Get full text

710 Relationship Between Partial Mayo Score and Patient-Reported Outcomes for Ulcerative Colitis Patients in the United States by Ding, Zhijie, Obando, Camilo, Izanec, James, Sikirica, Mirko, Lucas, James, Kemp, Jessalyn, Muser, Erik

“…INTRODUCTION: Measuring Patient-Reported Outcomes (PROs) is important in understanding how ulcerative colitis (UC) patients perceive their own health status…”
Get full text

763 Relationship Between Crohn's Disease Activity Index and Patient-Reported Outcomes for Crohn's Disease Patients in the United States by Obando, Camilo, Ding, Zhijie, Izanec, James, Sikirica, Mirko, Lucas, James, Kemp, Jessalyn, Muser, Erik

“…INTRODUCTION: Measuring Patient-Reported Outcomes (PROs) is important in understanding how Crohn's disease (CD) patients perceive their own health status and…”
Get full text

Persistence, Dose Titration, and Health Care Resource Utilization Among Crohn’s Disease Patients Treated With Ustekinumab: A Real-World Analysis in the United States by Obando, Camilo, Ding, Zhijie, Muser, Erik, Vaidya, Neel, Qiang, Wenqin, Sun, Xiaoxi, Wang, Huiqi, Mallampati, Rajesh, Xie, Lin

“…Introduction Crohn’s disease (CD) is a chronic inflammatory disease of the gastrointestinal tract. This real-world study evaluated persistence, dose titration,…”
Get full text

P082 Early assessment of ustekinumab for Crohn's disease: A chart review by Charles, Ruetsch, Tigwa, Davis, Jennifer, Clerie, Antuane, Allen, James, Izanec, Erik, Muser, Camilo, Obando

“…BACKGROUND: Ustekinumab was approved by the FDA in September 2016 for the treatment of patients with moderate-to-severe Crohn's Disease (CD). Little is…”
Get full text

Mo1875 EVALUATION OF BIOLOGIC TREATMENT PATTERNS AMONG CROHN'S DISEASE PATIENTS USING THREE LARGE UNITED STATES CLAIMS DATABASES by Muser, Erik, Obando, Camilo, Teeple, Amanda M., Bibeau, Wendy, Sah, Janvi, Mallampati, Rajesh, Wang, Huiqi, Xie, Lin

Get full text

762 Comorbidities and Opioid Use Among Patients With Crohn's Disease by Pilon, Dominic, Obando, Camilo, Ding, Zhijie, Voelker, Jennifer, Muser, Erik, Manceur, Ameur M., Kinkead, Frederic, Lafeuille, Marie-Hélène, Lefebvre, Patrick

“…INTRODUCTION: Comorbidities associated with Crohn's disease (CD) add to the symptoms of disease and may contribute to substantial disease burden. There is a…”
Get full text

711 Comorbidity Burden Among Patients With Ulcerative Colitis in the United States by Pilon, Dominic, Obando, Camilo, Ding, Zhijie, Voelker, Jennifer, Muser, Erik, Manceur, Ameur M., Kinkead, Frederic, Lafeuille, Marie-Hélène, Lefebvre, Patrick

“…INTRODUCTION: The symptoms and comorbidities associated with ulcerative colitis (UC) add to the disease burden. Long-term assessment of the comorbidities…”
Get full text